Your browser doesn't support javascript.
loading
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma.
Chari, Ajai; Lonial, Sagar; Mark, Tomer M; Krishnan, Amrita Y; Stockerl-Goldstein, Keith E; Usmani, Saad Z; Londhe, Anil; Etheredge, Delores; Fleming, Sarah; Liu, Baolian; Ukropec, Jon; Lin, Thomas S; Jagannath, Sundar; Nooka, Ajay K.
Afiliación
  • Chari A; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Lonial S; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Mark TM; Weill Cornell Medical College, New York, New York.
  • Krishnan AY; Department of Hematology and Hematopoietic Cell Transplantation and Judy and Bernard Briskin Center for Multiple Myeloma, City of Hope National Medical Center, Duarte, California.
  • Stockerl-Goldstein KE; Division of Medical Oncology - Bone Marrow Transplantation and Leukemia Section, Washington University, St. Louis, Missouri.
  • Usmani SZ; Levine Cancer Institute, Charlotte, North Carolina.
  • Londhe A; Janssen Research & Development, LLC, Titusville, New Jersey.
  • Etheredge D; Janssen Research & Development, LLC, Titusville, New Jersey.
  • Fleming S; Janssen Research & Development, LLC, Titusville, New Jersey.
  • Liu B; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Ukropec J; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania.
  • Lin TS; Janssen Scientific Affairs, LLC, Horsham, Pennsylvania.
  • Jagannath S; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Nooka AK; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Cancer ; 124(22): 4342-4349, 2018 11 15.
Article en En | MEDLINE | ID: mdl-30395359

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Anticuerpos Monoclonales / Mieloma Múltiple / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Anticuerpos Monoclonales / Mieloma Múltiple / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article